Tempus to Participate in the Stifel 2025 Healthcare Conference
News > Health News
Audio By Carbonatix
7:30 AM on Tuesday, October 28
The Associated Press
CHICAGO--(BUSINESS WIRE)--Oct 28, 2025--
Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced that it will participate in the Stifel 2025 Healthcare Conference on Thursday, November 13 in New York City. Jim Rogers, Chief Financial Officer at Tempus, will participate in a fireside chat at 10:00 AM ET.
The live webcast will be available through the events page of Tempus’ Investor Relations website or by clicking the following link: https://event.summitcast.com/view/cwkmPXkC4dosg6MoG95rxb/n5gWXXPJwMBQmjZjJYHqKv
About Tempus
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20251028098887/en/
CONTACT: Tempus Communications
Erin Carron
Erin.carron@tempus.comTempus Investor Relations
Elizabeth Krutoholow
investorrelations@tempus.com
KEYWORD: ILLINOIS NEW YORK UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: HEALTH DATA MANAGEMENT TECHNOLOGY HEALTH TECHNOLOGY ARTIFICIAL INTELLIGENCE
SOURCE: Tempus AI, Inc.
Copyright Business Wire 2025.
PUB: 10/28/2025 08:30 AM/DISC: 10/28/2025 08:31 AM
http://www.businesswire.com/news/home/20251028098887/en